Several studies have demonstrated that a combination strategy of an HDAC inhibitor with a TRAIL sensitizer has emerged as a potent strategy to prime cancer cells to TRAIL-mediated apoptosis in a variety of human cancers [48]. Here, TNFSF10 is linked to cancer.